{
    "2020-01-14": [
        [
            {
                "time": "2023-01-01",
                "original_text": "Eli Lilly ends deal with NextCure worth up to $1.4B for the local biotech",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "NextCure",
                        "deal ended",
                        "$1.4B"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-01-01",
                "original_text": "Eli Lilly Interested in Bolt-On Acquisitions, CEO Says",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "bolt-on acquisitions",
                        "CEO statement"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-01-01",
                "original_text": "Eli Lilly and Company -- Moody's announces completion of a periodic review of ratings of Eli Lilly and Company",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Moody's",
                        "rating review"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-01-01",
                "original_text": "Big Merger Deals Are Missing at Health Conference. Here’s Why.",
                "features": {
                    "keywords": [
                        "merger deals",
                        "health conference",
                        "missing deals"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-01-01",
                "original_text": "The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug",
                "features": {
                    "keywords": [
                        "PhaseBio",
                        "hypertension asset",
                        "Stemline",
                        "Q4 pre-announcement",
                        "FDA review",
                        "Nektar"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-01-01",
                "original_text": "Eli Lilly to make two more cheaper insulin products available from mid-April",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "cheaper insulin",
                        "mid-April"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-01-01",
                "original_text": "Lilly expands insulin affordability options with lower-priced versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen®",
                "features": {
                    "keywords": [
                        "Lilly",
                        "insulin affordability",
                        "lower-priced versions",
                        "Humalog"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}